{"id":"NCT00253747","sponsor":"University of Cincinnati","briefTitle":"Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)","officialTitle":"A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers With ADHD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-11","primaryCompletion":"2008-01","completion":"2008-03","firstPosted":"2005-11-15","resultsPosted":"2012-09-17","lastUpdate":"2012-09-17"},"enrollment":255,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["ADHD","Smoking"],"interventions":[{"type":"DRUG","name":"Osmotic-Release Methylphenidate","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Osmotic-Release Methylphenidate","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to evaluate whether Osmotic-Release Methylphenidate (OROS MPH), relative to placebo, increases the effectiveness of standard smoking treatment (i.e., nicotine patch and individual smoking cessation counseling) in obtaining prolonged abstinence for smokers with Attention Deficit Hyperactivity Disorder (ADHD).","primaryOutcome":{"measure":"Prolonged Abstinence","timeFrame":"Weeks 7-10","effectByArm":[{"arm":"Osmotic-Release Methylphenidate (OROS-MPH)","deltaMin":25,"sd":null},{"arm":"Osmotic-Release Methylphenidate (OROS-MPH) - Placebo","deltaMin":28,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["29370538","26272693","25659348","24229749","23339731","22955246","20492837","20219292"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":127},"commonTop":["Headache","Nervousness","Anxiety","Insomnia","Nasopharyngitis"]}}